Long-term Survival Outcomes of ‘Low Risk’ Ductal Carcinoma in situ from a Territory-wide Cancer Registry
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference24 articles.
1. In situ carcinoma of the breast;Silverstein,2002
2. Incidence of and treatment for ductal carcinoma in situ of the breast;Ernster;JAMA,1996
3. SEER cancer statistics review, 1975–2017;Howlader,2017
4. In situ breast cancer;Sprague,2010
5. National Institutes of Health state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ September 22–24, 2009;Allegra;J Natl Cancer Inst,2009
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Outcomes from low-risk ductal carcinoma in situ: a systematic review and meta-analysis;Breast Cancer Research and Treatment;2024-08-24
2. Imaging Changes and Outcomes of Patients Undergoing Active Monitoring for Ductal Carcinoma In Situ: Seven-Year Follow-up Study;Academic Radiology;2024-07
3. High-value breast cancer care within resource limitations;The Oncologist;2024-05-23
4. Should low-risk DCIS lose the cancer label? An evidence review;Breast Cancer Research and Treatment;2023-04-19
5. Clinical Outcomes of Conservative Treatment for Low-Risk Ductal Carcinoma in Situ: A Systematic Review and Pooled Analysis;Clinical Oncology;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3